In Stent Restenosis After Drug-Eluting Stent Implantation in a Patient with Polycythemia Vera: A Case Report

Authors

  • I Gusti Ayu Ratna Dewi Department of Emergency Medicine, Jantung Diagram Siloam Hospital, Depok, Indonesia
  • Tristi Lukita Wening Department of Emergency Medicine, Jantung Diagram Siloam Hospital, Depok, Indonesia
  • Sidhi Laksono Purwowiyoto Department of Cardiology and Vascular Medicine, Jantung Diagram Siloam Hospital, Depok, Indonesia; Faculty of Medicine, Universitas Muhammadiyah Prof. Dr. Hamka, Tangerang, Indonesia

DOI:

https://doi.org/10.19184/ams.v9i2.38765

Abstract

Polycythemia vera happened in people around 40-60 years old and mostly men. The criteria are total red blood cells ≥36 mL/kg in males, thrombocytosis, leukocytosis, and JAK2 mutation. We present a case of a 63-year-old male with unknown history of polycythemia vera who came to our hospital with acute STEMI anterior, he previously had done a coronary angiogram at another hospital thirteen days ago and found out that his previous drug-eluting stent (DES) was total in-stent restenosis in proximal. To prevent recurrent ischemia events, we replaced Clopidogrel with Ticagrelor and continue Aspirin.

Keywords: drug-eluting stent; in-stent restenosis; polycythemia vera

Downloads

Download data is not yet available.

Downloads

Published

2023-06-30

Issue

Vol. 9 No. 2 (2023)

Section

Case Report Article